较低危MDS患者与年龄和性别匹配参考人群的健康相关生活质量比较:一项欧洲白血病网研究
该研究基于欧洲白血病网注册库,采用EQ-5D问卷评估1690例连续纳入的IPSS低危/中危-1型MDS患者初诊时健康相关生活质量,并与年龄和性别匹配的EuroQol组常模比较。结果显示患者疼痛/不适、活动能力、焦虑/抑郁及日常活动维度中重度问题比例显著高于匹配同龄人群。
要点
- 初诊较低危MDS患者中,49.5%报告疼痛/不适中重度问题,41.0%活动能力受限。
- 焦虑/抑郁(37.9%)和日常活动(36.1%)中重度问题比例亦较高。
- 与年龄和性别匹配同龄人相比,MDS患者日常活动和焦虑/抑郁问题比例显著更高(p < 0.001)。
核心结论
- 新诊断IPSS较低危MDS患者健康相关生活质量明显降低,且多个维度受限聚集出现,与参考人群相比差异显著。
研究设计与样本
- 欧洲白血病网注册库前瞻性研究,连续纳入1690例初诊IPSS低危/中危-1型MDS患者,采用EQ-5D问卷评估健康相关生活质量,并与年龄和性别匹配的EuroQol组常模比较。
主要发现
- 疼痛/不适、活动能力、焦虑/抑郁和日常活动维度中重度问题比例分别为49.5%、41.0%、37.9%和36.1%。
- 活动能力、自我照顾、日常活动、疼痛/不适及EQ-VAS受限在老年人、女性、高合并症负担、低血红蛋白水平或需红细胞输注者中显著更常见(p < 0.001)。
- 与年龄和性别匹配同龄人相比,MDS患者日常活动和焦虑/抑郁问题比例显著更高(p < 0.001)。
- 活动能力受限在男性和老年人中最突出(p < 0.001);焦虑/抑郁受限在女性和年轻人中最突出(p < 0.001);EQ-VAS受限在女性和75岁以上人群中显著(p < 0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In myelodysplastic syndromes (MDS), health-related quality of life (HRQoL) represents a relevant patient-reported outcome, which is essential in individualized therapy planning. Prospective data on HRQoL in lower-risk MDS remain rare. We assessed HRQOL by EQ-5D questionnaire at initial diagnosis in 1690 consecutive IPSS-Low/Int-1 MDS patients from the European LeukemiaNet Registry. Impairments were compared with age- and sex-matched EuroQol Group norms. A significant proportion of MDS patients reported moderate/severe problems in the dimensions pain/discomfort (49.5%), mobility (41.0%), anxiety/depression (37.9%), and usual activities (36.1%). Limitations in mobility, self-care, usual activities, pain/discomfort, and EQ-VAS were significantly more frequent in the old, in females, and in those with high co-morbidity burden, low haemoglobin levels, or red blood cells transfusion need (p < 0.001). In comparison to age- and sex-matched peers, the proportion of problems in usual activities and anxiety/depression was significantly higher in MDS patients (p < 0.001). MDS-related restrictions in the dimension mobility were most prominent in males, and in older people (p < 0.001); in anxiety/depression in females and in younger people (p < 0.001); and in EQ-VAS in women and in persons older than 75 years (p < 0.05). Patients newly diagnosed with IPSS lower-risk MDS experience a pronounced reduction in HRQoL and a clustering of restrictions in distinct dimensions of HRQoL as compared with reference populations.
引用
- Stauder R, Yu G, Koinig KA, et al. Health-related quality of life in lower-risk MDS patients compared with age- and sex-matched reference populations: a European LeukemiaNet study. Leukemia. 2018. PMID: 29572506. doi:10.1038/s41375-018-0089-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。